
The baby saved from a rare disease by a first-ever personalized gene fix has reached a big milestone, taking his first steps ahead of Christmas.
KJ Muldoon is walking and getting ready to celebrate the holiday season at home with his parents and three siblings.
KJ was born last year with a genetic disorder called carbamoyl-phosphate synthetase 1 deficiency. Also known as CPS1 deficiency, the metabolic condition affects only 1 in 1.3 million babies and often leads to life-threatening outcomes.
When he was 6 months old, doctors began giving KJ a groundbreaking new treatment -- a personalized CRISPR gene editing therapy at Children's Hospital of Philadelphia.
Doctors save baby's life with first-ever gene fix for deadly rare disease
The gene-editing therapy works like a "molecular spell-checker,” finding and fixing the specific genetic error causing his condition.
After three infusions and after spending the first 10 months of his life in a hospital, KJ was discharged and sent home in June.
Baby saved by gene-editing therapy 'graduates' from hospital, goes home
Since then, KJ has continued to grow and thrive with his family, celebrating his first birthday at home and taking part in one of the family’s favorite rituals -- cheering for their beloved Philadelphia Eagles.
Doctors hope new technology like CRISPR gene-editing therapies can be the key to treating more than 7,000 rare diseases, such as sickle cell disease, cystic fibrosis, Huntington’s disease and muscular dystrophy, that affect approximately 30 million people across the country.
latest_posts
- 1
Artemis II astronauts are more than halfway to the moon as they seek to break Apollo 13's record - 2
Signature Scents: A Manual for Outstanding Fragrances - 3
Starfront Observatories: A haven for distant stargazers - 4
Israel says 40 Hezbollah members killed as forces advance in Lebanon - 5
Trump awarded 1st FIFA Peace Prize by Gianni Infantino at 2026 World Cup draw
How to watch 'A Charlie Brown Christmas' for less with this Apple TV Black Friday deal
Israel scales back use of top missile interceptors as Iran barrages persist
CRP Subsea secures contract for Vattenfall’s Nordlicht I cable systems
Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer's trials
German state railway loss widens, passengers warned of trouble ahead
Safeguarding Your Senior Protection Against Extortion and Tricks.
A definitive Manual for Well known Fragrances
The Job of Attorneys: It is Important to Comprehend When Legitimate Help
Popular Japanese Hotel Chain Now Lets You Show Up With Just Your Passport













